$0.649000
0.057.74%
At Close: -
$0.667000
0.022.77%
After Hours: Sep 20, 7:51 PM EDT
15 minutes delayed
Comments
Loading...
BriaCell Therapeutics (BCTX) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestBriaCell Therapeutics (NASDAQ:BCTX) Stock Quotes, Forecast and News Summary
BriaCell Therapeutics Stock (NASDAQ: BCTX) stock price, news, charts, stock research, profile.
| Open | $0.59 |
| Close | $0.65 |
| Volume / Avg. | 2.89M / 3.45M |
| Day Range | $0.57 - $0.66 |
| 52 Wk Range | 0.46 - 6.36 |
| Market Cap | $20.48M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 49 |
| Short Interest | 0.88% |
| Days to Cover | 1.15 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About
Sector
Healthcare
Industry
N/A
BriaCell Therapeutics Corp is a clinical-stage immuno-oncology company. The group is developing an e...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy BriaCell Therapeutics (BCTX) stock?
You can purchase shares of BriaCell Therapeutics (NASDAQ:BCTX) through any online brokerage.
Who are BriaCell Therapeutics (BCTX) competitors?
There are no as such competitors for BriaCell Therapeutics.
What is the forecast, or price target, for BriaCell Therapeutics (BCTX) stock?
BriaCell Therapeutics has a consensus price target of $15.00.
What is the current price for BriaCell Therapeutics (BCTX)?
The stock price for BriaCell Therapeutics (NASDAQ: BCTX) is $0.667 last updated September 20, 2024 at 7:51 PM EDT.
Does BriaCell Therapeutics (BCTX) pay a dividend?
There are no upcoming dividends for BriaCell Therapeutics.
When is BriaCell Therapeutics (NASDAQ:BCTX) reporting earnings?
BriaCell Therapeutics’s Q1 earnings are confirmed for Thursday, December 12, 2024.
Is BriaCell Therapeutics (BCTX) going to split?
There is no upcoming split for BriaCell Therapeutics.
What sector and industry does BriaCell Therapeutics (BCTX) operate in?
BriaCell Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.